AIC
CCXI

Ameritas Investment Company’s ChemoCentryx, Inc. CCXI Stock Holding History

Ameritas Investment Company’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,000
Closed -$11K – 1901
2018
Q4 		$11K Buy
+1,000
New +$10.5K ﹤0.01% 1032

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameritas Investment Company's CCXI Position: Q1 2019 in Review

Ameritas Investment Company sold out of ChemoCentryx, Inc. (CCXI) in Q1 2019, closing a stake of 1,000 shares — an estimated $11K sold.

Ameritas Investment Company first reported a position in CCXI in Q4 2018 and held it in 1 quarter. The position peaked at $11K in Q4 2018. 117 funds tracked by Wall St. Rank hold CCXI as of Q1 2019.

  • Ameritas Investment Company reported no remaining ChemoCentryx, Inc. position as of Q1 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 1,000 ChemoCentryx, Inc. shares in Q1 2019, an estimated $11K.
  • Ameritas Investment Company first reported a position in ChemoCentryx, Inc. in Q4 2018 and held it in 1 quarter.
  • Ameritas Investment Company's ChemoCentryx, Inc. position peaked at $11K in Q4 2018.
  • 117 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2019.

Based on Ameritas Investment Company's 13F filing for Q1 2019, filed 16 May 2019.